2017
Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood
Eguchi A, Lazaro R, Wang J, Kim J, Povero D, Willliams B, Ho S, Stärkel P, Schnabl B, Ohno‐Machado L, Tsukamoto H, Feldstein A. Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. Hepatology 2017, 65: 475-490. PMID: 27639178, PMCID: PMC5407075, DOI: 10.1002/hep.28838.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnalysis of VarianceAnimalsBiopsy, NeedleCells, CulturedDisease Models, AnimalExtracellular VesiclesFatty Liver, AlcoholicHepatocytesHumansImmunoblottingImmunohistochemistryMiceMicroRNAsMiddle AgedRandom AllocationReal-Time Polymerase Chain ReactionSampling StudiesSeverity of Illness IndexStatistics, NonparametricYoung AdultConceptsBlood extracellular vesiclesLiver injuryExtracellular vesiclesNuclear factor kappa BAlcoholic liver diseaseChronic liver injuryWeeks of infusionBile duct ligationB-cell lymphoma 2Levels of EVsFactor kappa BSteatohepatitis developmentNonalcoholic steatohepatitisLiver diseaseObese miceHepatic macrophagesDuct ligationKappa BMiR-340Cell originLymphoma 2Intragastric infusionMiceMiRNA signatureTime points
2007
Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates
Liu F, Jenssen T, Trimarchi J, Punzo C, Cepko C, Ohno-Machado L, Hovig E, Patrick Kuo W. Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates. BMC Genomics 2007, 8: 153. PMID: 17555589, PMCID: PMC1899500, DOI: 10.1186/1471-2164-8-153.Peer-Reviewed Original ResearchConceptsDNA microarray platformMicroarray platformSequencing-based approachesSequencing-based technologiesGene expression technologyGene expression profilingTranscriptome profilingBiological replicatesExpression profilingExpression technologyGene expressionDifferential expressionBiomarker discoveryProfilingExpressionMicroarrayImportant tool
2001
Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors
Resnic F, Blake G, Ohno-Machado L, Selwyn A, Popma J, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. The American Journal Of Cardiology 2001, 88: 493-496. PMID: 11524056, DOI: 10.1016/s0002-9149(01)01725-8.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedAnalysis of VarianceAneurysm, FalseAngioplasty, Balloon, CoronaryAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedArteriovenous FistulaChi-Square DistributionCoronary DiseaseCoronary Vessel AnomaliesCoronary VesselsEquipment SafetyFemaleHematomaHumansIncidenceMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionProbabilityRetrospective StudiesRisk AssessmentRisk FactorsSex DistributionConceptsPercutaneous coronary interventionVascular closure deviceGlycoprotein IIb-IIIa antagonistsVascular complication ratesVascular complicationsClosure deviceCoronary interventionComplication rateLower vascular complication ratesOverall vascular complication rateGlycoprotein IIb-IIIa inhibitorsIIb-IIIa inhibitorsSubgroup of patientsLength of stayHospital stayConsecutive patientsLarge hematomaSurgical repairArteriovenous fistulaPatient populationUnivariate analysisRetrospective analysisComplicationsPatient comfortPatients
2000
Major complications after angioplasty in patients with chronic renal failure: a comparison of predictive models.
Lacson R, Ohno-Machado L. Major complications after angioplasty in patients with chronic renal failure: a comparison of predictive models. AMIA Annual Symposium Proceedings 2000, 457-61. PMID: 11079925, PMCID: PMC2243840.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyEnd-stage renal diseaseChronic renal failureMajor complicationsRenal failureCongestive heart failurePatient risk factorsTransluminal coronary angioplastyLogistic regression modelsCoronary angioplastyHeart failureRenal diseasePoor outcomeMyocardial infarctionRisk factorsPrior historyPresence of shockComplicationsLogistic regressionPatientsDiscriminatory abilityDemographic characteristicsAngioplastyRegression modelsStandard logistic regression model
1998
Diagnosing breast cancer from FNAs: variable relevance in neural network and logistic regression models.
Ohno-Machado L, Bialek D. Diagnosing breast cancer from FNAs: variable relevance in neural network and logistic regression models. 1998, 52 Pt 1: 537-40. PMID: 10384515.Peer-Reviewed Original ResearchMeSH KeywordsAnalysis of VarianceBiopsy, NeedleBreast NeoplasmsFemaleHumansLogistic ModelsMultivariate AnalysisNeural Networks, Computer